Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could heat zap fibroids without surgery?

NCT ID NCT07780019

Symptom relief Sponsor: Turku University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 21, 2026 · Last updated Aug 21, 2026

Summary

This study looks at whether a procedure called microwave ablation can safely and effectively treat symptomatic uterine fibroids in 100 premenopausal women. The procedure uses ultrasound guidance to deliver heat directly to the fibroids, aiming to shrink them and reduce symptoms like heavy bleeding and pain. Researchers will measure changes in symptom severity and quality of life using a validated questionnaire, and also assess how well the technique works across different fibroid types, sizes, and locations.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
microwave ablation
What this could lead to
If successful, this could offer a minimally invasive alternative to surgery for treating symptomatic uterine fibroids, potentially easing pain and heavy bleeding while preserving the uterus.
What could go wrong
This is an observational study, not a randomized trial, so results may be less definitive. The procedure carries risks like bleeding or injury, and its effectiveness may vary depending on fibroid type, size, and location.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2026

Expected to finish

Dec 2034

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

patients undergoing mwa for symptomatic uterine fibroids will be recruited for this study

Ages

18 to 56 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * symptomatic fibroids * premenopausal status * acceptable risks for general anestesia or sedation * willing to undergo mwa treatment and participate in the study Exclusion Criteria: * postmenopausal status * bleeding disorder with increased risk of bleeding

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Uterine fibroids (leiomyoma) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

leiomyoma uterine corpus leiomyoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Uterine fibroids (leiomyoma)

Contacts and locations

Locations

  • Turku University Hospital

    Turku, Finland

More trials for these conditions

Other studies related to the condition(s) this trial covers.